Leading tech companies are in a race to release and improve artificial intelligence (AI) products, leaving users in the United States to puzzle out how much of their personal data could be extracted ...

Novo Nordisk remains a Strong Buy despite recent earnings misses, trial setbacks, and competitive pressures in the weight loss/diabetes market. NVO's valuation is compelling, trading at a low P/E of ...

With student needs shifting and AI reshaping work, universities must close the gap between expectations and delivery through flexible learning, interoperable credentials and smarter use of technology ...